Modulation of bcl11a for treatment of hemoglobinopathies

Details Modulation of bcl11a for treatment of hemoglobinopathies Modulation of bcl11a for treatment of hemoglobinopathies

C - Chemistry, Metallurgy

12

N

C12N 15/63 (2006.01) A61K 48/00 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2737180

The invention relates to methods and uses of modulating fetal hemoglobin expression (HbF) in a hematopoietic progenitor cells via inhibitors of BCL11A expression or activity, such as RNAi and antibodies.

La présente invention concerne des procédés et des utilisations de modulation de l'expression d'hémoglobine ftale (HbF) dans des cellules progénitrices hématopoïétiques par l'intermédiaire d'inhibiteurs de l'expression ou l'activité de BCL11A, tels que des ARNi et des anticorps.

Affiliated with

Also associated with

Rating

Modulation of bcl11a for treatment of hemoglobinopathies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of bcl11a for treatment of hemoglobinopathies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of bcl11a for treatment of hemoglobinopathies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1798699